Director TitleAgeSince
Director/Board Member - 01/10/2010
Director/Board Member - 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
+1.33%-2.26%+16.81%+67.05% 46.96B
+0.12%-1.59%+47.86%+123.16% 39.63B
-0.64%-2.80%-8.19%+15.25% 12.07B
-0.99%-8.34%+11.63%+69.12% 11.61B
+0.58%0.00%+30.65%+147.62% 9.11B
+0.39%-0.38%+20.86%+40.63% 7.47B
+0.80%+1.82%+43.27%-11.49% 7.18B
-2.54%-1.90%+15.45%+189.85% 6.79B
-0.97%-2.30%-30.37%+24.93% 5.75B
Average +17,989.81%-1.80%+16.44%+74.01% 16.29B
Weighted average by Cap. +0.48%-2.90%+23.19%+81.97%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock